Ischemic stroke commonly affects older individuals in China and worldwide. Such events are caused by a blood clot that blocks a vessel supplying blood to the brain. However, the etiology and pathogenesis of ischemic stroke are not fully understood. Genetics may play an important role in these events; indeed, rapid progress through the Human Genome Project has allowed the localisation and identification of genes related to ischemic stroke (1). Some single-gene disorders such as Fabry disease and sickle cell disease include ischemic stroke as a feature of the disorder, while in other cases, genetic variants appear to increase individual susceptibility to ischemic events.
Chinese individuals by an association with altered blood chemistry. In this study, the association of ITGA2 and ITGB3 polymorphisms with ischemic stroke was determined by using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) in a Chinese population. Additionally, blood lipids which, when elevated, can contribute to ischemic events were compared among genotypes to provide a theoretical basis for the pathogenesis of ischemic stroke through integrin polymorphisms.
MATERIAL AND METHODS

Participants
From February 2010 to February 2012, patients admitted to the First People's Hospital of Yancheng City (Affiliated Hospital of Yancheng Health Vocational & Technical College) for ischemic stroke were selected as the study population ('patient' group, n=350). This group included 207 males and 143 females, aged 35-76 years (mean age, 55.7±12.2 years), with 132 cases with a smoking history and 153 with an alcohol consumption history. Diagnosis was made according to the Fourth National Cerebrovascular Disease Diagnostic Criteria (10) , and all patients were confirmed by clinical symptoms and brain Computed Tomography (CT) or Magnetic Resonance Imaging (MRI) scan. The study criteria excluded patients with cardiogenic stroke and any strokes caused by arteritis, trauma, blood disease, medication, tumours, cerebral vascular malformation, or aneurysm. A control group comprised 300 healthy people who received physical examination in our hospital during the same time period. This group included 184 males and 116 females, aged 32-73 years (mean age, 54.6±11.0 years). The control group excluded individuals with the following diseases and conditions: stroke, liver, kidney and blood disease, autoimmune disease, thyroid disease, pregnancy, and cerebrovascular disease history. The two groups were not statistically different in age or gender. The study was approved by the Ethics Committee of the First People's Hospital of Yancheng City (Affiliated Hospital of Yancheng Health Vocational & Technical College).
Genomic DNA extraction
Venous blood samples (3 mL) were collected from each individual into EDTA-K2-treated anticoagulant tubes. A modified sodium iodide method was used to extract leukocyte genomic DNA (11), which was then stored at -80°C until use.
PCR amplification
ITGA2 and ITGA3 were amplified by PCR. Primers were obtained from Sangon Biological Engineering Co., Ltd. (Shanghai, China). ITGA2 primers were as follows: upstream of C807T, 5'-GCCAATA-ATCCAAGAGTTGTGTT-3' and downstream, 5'-TATTTTCTTG-CATATTGAATTGCTTC-3'; ITGB3 primers were as follows: upstream of T176C, 5'-CTTAGCTATTGGGAAGTGGTAGG-3' and downstream, 5'-ACTGACTTGAGTGACCTGGGAG-3'. Reactions were performed using 2.5 mL 10× PCR buffer, 2.0 mL 2.5 mmol/L dNTPs, 20 pmol upstream primer and 20 pmol downstream primer, 2.0 mL template DNA, and 1.25 U Taq DNA polymerase, brought to a 25 mL total reaction volume with sterilised double-distilled water. Amplification proceeded in a thermal cycler (Bio-Rad) under the following conditions: 94°C for 5 minutes; 94°C for 30 seconds, 65°C for 45 seconds, and 72°C for 45 seconds for 35 cycles; and 72°C for 5 minutes.
Restriction digestion
PCR amplification products were digested with restriction enzymes to identify polymorphisms; 3 µL product was combined with 2 U BstBI and MspI (Bio-labs, United Kingdom) to identify ITGA2 C807T and ITGB3 T176C, respectively. Reactions were performed at 37°C for 3 hours, then products were identified by electrophoresis on an 8% polyacrylamide gel stained with ethidium bromide. A gel imaging system was used to visualise products.
Determination of blood lipid profiles
Enzymatic methods were used to determine serum total cholesterol (TC) and triglycerides (TG) levels. The masking method was used to directly determine high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C) levels. Dual-wavelength immunological transmission turbidimetry was used to determine apolipoprotein (Apo) A and Apo B. All determinations were performed on an OLYMPUS AU1000 automatic biochemical analyser (OLYMPUS Corporation, Japan). SPSS 13 .0 software was used for statistical analyses. Genotype and allele frequencies were calculated with the direct gene counting method of Smith (1957) . Congruence between the study objective and Hardy-Weinberg equilibrium and genotype and allele frequencies between groups were analysed with the χ 2 test. The degree of relative risk was expressed by the odds ratio (OR) and its 95% confidence interval (CI). Measurement data are presented as mean±standard deviation (x -±s), and t test was used to compare inter-group lipid and lipoprotein levels. All analyses were two-sided, with α level of 0.05 and p<0.05 considered as statistically significant.
Statistical analysis
RESULTS
ITGA2 and ITGB3 polymorphisms
RFLP for the ITGA2 C807T polymorphism produced three possible allele combinations: CC (two bands, 110 bp and 27 bp; band 27 bp ran out of the gel), CT (three bands, 137 bp, 110 bp, and 27 bp; band 27 bp ran out of the gel); or TT (one band, 137 bp), as shown in Figure 1a . Similarly, RFLP for the ITGB3 T176C polymorphism produced three possible allele combinations: TT (one band, 256 bp), TC (three bands, 256 bp, 154 bp, and 102 bp), or CC (two bands, 154 bp, 102 bp; not detected in this study), as shown in Figure 1b .
The distribution of ITGA2 and ITGB3 genotypes within both the control and patient groups reached Hardy-Weinberg equilibrium. However, χ 2 and correlation analyses revealed significant differences between the two groups in the distribution of the ITGA2 C807T genotype and allele frequencies (p<0.05). Additionally, relative risk analysis of allele frequency showed that patients with the T allele were 1.226 times more likely to suffer from ischemic stroke than patients with the C allele (OR=1.226, 95% CI=1.053-1.428) ( Table 1 ). In contrast, no significant difference was observed in the genotype or allele frequencies for ITGB3 T176C between the two groups ( Table 2 ).
Blood lipid profiles
In patients suffering from ischemic stroke, mean serum TC, TG, and LDL-C levels were all significantly higher than in the control group (p<0.05); serum HDL-C, Apo A, and Apo B were not different ( Table 3 ). The mean TC levels of patients carrying the T allele at ITGA2 807 (CT and TT genotypes) were significantly higher compared with those of patients carrying the CC genotype (p<0.05), but TG, LDL-C, HDL-C, Apo A, and Apo B levels were not different (Table 4 ). Blood lipid profiles were not significantly different between TT and TC genotypes in ITGB3 (Table 5) .
DISCUSSION
Adhesion molecules are glycoproteins that can mediate interactions among cells or between cells and the extracellular matrix. These proteins can aid white blood cells and platelets in adhering to the vascular endothelium, thereby facilitating the formation of cerebral atherosclerotic plaques (12) . As two key members of the integrin family of adhesion molecules, ITGA2 and ITGB3 are able to mediate cell-cell, cell-matrix, and cell-matrix-cell adhesions. These proteins, therefore, play important roles in the physiological and pathological processes of inflammatory reaction, immune response, atherosclerosis, thrombosis, etc. (13, 14) . Studies have indeed associated ITGA2 and ITGB3 polymorphisms with atherosclerotic diseases (15) (16) (17) .
Because findings of correlations between ITGA2 and ITGA3 polymorphisms and ischemic stroke have been conflicting, we assessed ITGA2 C807T and ITGB3 T176C polymorphisms in 350 ischemic stroke patients and 300 healthy controls in China. Our findings indicated that ischemic stroke risk was higher in individuals with a T allele, suggesting that the T allele may be a hereditary susceptibility gene for cerebral stroke. To understand the potential mechanistic contribution of the ITGA2 C807T polymorphism to stroke, we also investigated differences in blood lipid levels. Elevated blood lipids, particularly LDL-C and TG, contribute to the formation of atherosclerotic plaques and the inflammatory process that can lead to stroke. Unsurprisingly, patients suffering from ischemic stroke exhibited higher levels of TC, TG, and LDL-C than controls. Further, the ITGA2 C807T polymorphism affected blood lipid levels, with significantly higher TC levels in ischemic stroke patients carrying the T allele than those with the C allele. Therefore, individuals with the T allele have increased TC that may then increase the likelihood of ischemic stroke. In contrast, the ITGB3 T176C polymorphism did not lead to significant differences in allele or genotype frequencies or lipid profiles between patients and controls. Therefore, the ITGB3 T176C polymorphism appears to have no correlation with ischemic stroke.
In summary, the ITGA2 C807T polymorphism is correlated with ischemic stroke. In particular, the T allele may be a hereditary susceptibility allele for cerebral stroke, possibly because the allele leads to increased TC levels. 
